within Pharmacolibrary.Drugs.D_Dermatologicals.D11A_OtherDermatologicalPreparations.D11AX09_Oxaceprol;
model Oxaceprol 
   extends Pharmacolibrary.Drugs.ATC.D.D11AX09;

  annotation(Documentation(
    info ="<html><body><p>Oxaceprol is a derivative of hydroxyproline used as an anti-inflammatory agent in the treatment of osteoarthritis and other degenerative joint diseases. It acts by inhibiting the migration of leukocytes and thus mediates anti-inflammatory effects. It is not widely approved or in use in all countries today.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for an average healthy adult after oral administration due to lack of published human PK models.</p><h4>References</h4><ol><li><p>Lachmann, G, et al., &amp; Kusche, W (1990). Pharmacokinetics and metabolism of 14C-oxaceprol in beagle dogs after intramuscular and oral administration. <i>Arzneimittel-Forschung</i> 40(2 Pt 1) 200–206. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2334462/&quot;>https://pubmed.ncbi.nlm.nih.gov/2334462</a></p></li><li><p>Alarçin, E, et al., &amp; Bal-Ozturk, A (2020). Development and characterization of oxaceprol-loaded poly-lactide-co-glycolide nanoparticles for the treatment of osteoarthritis. <i>Drug development research</i> 81(4) 501–510. DOI:<a href=&quot;https://doi.org/10.1002/ddr.21642&quot;>10.1002/ddr.21642</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31958153/&quot;>https://pubmed.ncbi.nlm.nih.gov/31958153</a></p></li><li><p>Pawar, HS, et al., &amp; Mitra, A (2018). Comparative evaluation of therapeutic efficacy of intra-articular oxaceprol with conventional modalities in osteoarthritis animal model. <i>Clinical rheumatology</i> 37(8) 2195–2201. DOI:<a href=&quot;https://doi.org/10.1007/s10067-018-4087-1&quot;>10.1007/s10067-018-4087-1</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29637484/&quot;>https://pubmed.ncbi.nlm.nih.gov/29637484</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Oxaceprol;
